Multiple Myeloma Management vs SurvivorNet Utilisation & Stats

Bispecific antibodies are a novel mechanism in the management in the relapsed/refractory multiple myeloma. Recognizing the mechanism of these agents as well as preliminary efficacy data is important in considering clinical trials and implementing approved bispecific antibodies in the management of multiple myeloma.
  • Apple App Store
  • Gratuit
  • Médical

Classement dans le store

- -

We believe far too many people still struggle to find information about treatments that can save their lives. SurvivorNet is closing this gap by creating a deep, video-based educational resource for patients featuring top physicians and researchers around the country. To create patient-focused educational content, the company is working with physicians at leading NCCN-designated cancer centers such as The National Cancer Institute, Dana-Farber, Memorial Sloan Kettering, Stanford, NYU, and M.D. Anderson.
  • Apple App Store
  • Gratuit
  • Santé & Fitness

Classement dans le store

- -

Comparaison des classements Multiple Myeloma Management vs. SurvivorNet

Comparez l'évolution du classement de Multiple Myeloma Management au cours des 28 derniers jours à celle de SurvivorNet.

Rank

Aucune donnée disponible

Comparaison des classements Multiple Myeloma Management et SurvivorNet par pays

Comparez l'évolution du classement de Multiple Myeloma Management au cours des 28 derniers jours à celle de SurvivorNet.

Aucune donnée à afficher

Comparez avec n'importe quel site grâce à notre essai gratuit

Démarrer
Multiple Myeloma Management VS.
SurvivorNet

19écembre d, 2024